Antibody Engineering 2. bis 6. Dezember 2001 - 500 Beiträge pro Seite
eröffnet am 11.10.01 20:42:11 von
neuester Beitrag 27.11.01 18:54:20 von
neuester Beitrag 27.11.01 18:54:20 von
Beiträge: 2
ID: 486.726
ID: 486.726
Aufrufe heute: 0
Gesamt: 293
Gesamt: 293
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 39 Minuten | 3585 | |
| 01.05.24, 18:36 | 2385 | |
| vor 1 Stunde | 2256 | |
| gestern 19:24 | 1858 | |
| vor 1 Stunde | 1485 | |
| vor 37 Minuten | 1447 | |
| gestern 18:35 | 1315 | |
| vor 31 Minuten | 1227 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.001,60 | +0,59 | 240 | |||
| 2. | 2. | 168,20 | +0,08 | 87 | |||
| 3. | 3. | 9,7000 | +12,27 | 75 | |||
| 4. | 14. | 6,1400 | -1,35 | 69 | |||
| 5. | 11. | 0,1865 | 0,00 | 52 | |||
| 6. | 7. | 0,8750 | -12,50 | 47 | |||
| 7. | 12. | 0,1561 | +2,97 | 38 | |||
| 8. | 6. | 2.302,50 | 0,00 | 36 |
Feedback
Gastredner:
Distinguished Faculty
Biomolecular Diversity
Dr. Andrew Bradbury, Los Alamos National Laboratory and SISSA, Italy
Dr. George Georgiou, University of Texas, Austin
Dr. Renè M.A. Hoet, Dyax s.a.
Dr. Brian R. Kay, University of Wisconsin- Madison
Dr. James D. Marks, University of California, San Francisco
Dr. Titus Kretzschmar, Morphosys
Dr. Andreas Plückthun, Zürich University, Switzerland
Dr. Andrew Porter, University of Aberdeen, Scotland
Dr. K. Dane Wittrup, Massachusetts Institute of Technology
Antobody Engineering
Dr. Gregory P. Adams, Fox Chase Cancer Center
Dr. Richard Begent, Royal Free and University College Medical School, United Kingdom
Dr. Arya Biragyn, National Cancer Institute, National Institutes of Health
Dr. Yves Boucher, Massachusetts General Hospital
Dr. Andrew Bradbury, Los Alamos National Laboratory and SISSA, Italy
Dr. Dennis Burton, The Scripps Research Institute
Dr. Frank J. Carr, Biovation Limited, United Kingdom
Dr. C. Geoffrey Davis, Abgenix, Inc.
Dr. Henrik J. Ditzel, The Scripps Research Institute
Dr. Robert B. Fick, Jr., Genentech
Dr. Andrew J.T. George, Imperial College, United Kingdom
Dr. Stephen D. Gillies, Lexigen Pharmaceuticals Corp
Dr. Martin J. Glennie, University of Southampton, United Kingdom
Dr. David R. Glover, Cambridge Antibody Technology, United Kingdom
Dr. Lucy Holt, MRC Laboratory of Molecular Biology, United Kingdom
Dr. Annemarie Honegger, Zürich University, Switzerland
Dr. Hennie R. Hoogenboom, Dyax Corp and University of Liëge, Belgium
Dr. James S. Huston, Lexigen Pharmaceuticals Corp
Isao Ishida, Kirin Brewery Co., Ltd., Japan
Dr. Lutz Jermutus, Head of Display Technology Development, Cambridge Antibody Technology, United Kingdom
Dr. Titus Kretzschmar, Morphosys, Germany
Dr. Dasa Lipovsek, Phylos, Inc.
Dr. T. Logtenberg, Crucell N.V., The Netherlands
Dr. Nils Lonberg, Medarex
Dr. Wayne A. Marasco, Harvard Medical School
Dr. James D. Marks, University of California, San Francisco
Dr. Ole J. Marvik, Affitech AS, Norway
Dr. Serge Muyldermans, Vrije Universiteit Brussel, Belgium
Dr. Dario Neri, Swiss Federal Institute of Technology, Switzerland
Dr. Peter O. Olins, Applied Molecular Evolution, Inc.
Dr. John W. Park, University of California, San Francisco
Dr. Paul W.H.I. Parren, The Scripps Research Institute
Dr. Ira Pastan, National Cancer Institute, National Institutes of Health
Dr. R. Barbara Pedley, Royal Free and University College Medical School, United Kingdom
Dr. Alexander Pereboev, University of Alabama at Birmingham
Dr. Andreas Plückthun, Zürich University, Switzerland
Dr. Jos Raats, University of Nijmegen, The Netherlands
Dr. Mitchell Reff, IDEC Pharmaceuticals
Dr. Ralph A. Reisfeld, The Scripps Research Institute
Dr. Jamie Kathleen Scott, Simon Fraser University, Canada
Dr. Jack L. Strominger, Harvard University & Harvard Medical School
Dr. Jean-Luc Teillaud, INSERM, France
Dr. Ian M. Tomlinson, Diversys Limited, United Kingdom
Dr. Gunars Valkers, Biosite Discovery
Dr. Ellen Vitetta, The University of Texas Southwestern Medical Center at Dallas
Dr. Gerhard Wagner, Harvard Medical School
Dr. Jeffry D. Watkins, Applied Molecular Evolution, Inc.
Dr. Louis M. Weiner, Fox Chase Cancer Center
Dr. R. Anthony Williamson, The Scripps Research Institute
Dr. Jan G.J. van de Winkel, Genmab A/S, The Netherlands
Dr. K. Dane Wittrup, Massachusetts Institute of Technology
http://www.lifesciencesinfo.com/antibodyeng/?source=2680-35
Gruß Bogo!
Distinguished Faculty
Biomolecular Diversity
Dr. Andrew Bradbury, Los Alamos National Laboratory and SISSA, Italy
Dr. George Georgiou, University of Texas, Austin
Dr. Renè M.A. Hoet, Dyax s.a.
Dr. Brian R. Kay, University of Wisconsin- Madison
Dr. James D. Marks, University of California, San Francisco
Dr. Titus Kretzschmar, Morphosys
Dr. Andreas Plückthun, Zürich University, Switzerland
Dr. Andrew Porter, University of Aberdeen, Scotland
Dr. K. Dane Wittrup, Massachusetts Institute of Technology
Antobody Engineering
Dr. Gregory P. Adams, Fox Chase Cancer Center
Dr. Richard Begent, Royal Free and University College Medical School, United Kingdom
Dr. Arya Biragyn, National Cancer Institute, National Institutes of Health
Dr. Yves Boucher, Massachusetts General Hospital
Dr. Andrew Bradbury, Los Alamos National Laboratory and SISSA, Italy
Dr. Dennis Burton, The Scripps Research Institute
Dr. Frank J. Carr, Biovation Limited, United Kingdom
Dr. C. Geoffrey Davis, Abgenix, Inc.
Dr. Henrik J. Ditzel, The Scripps Research Institute
Dr. Robert B. Fick, Jr., Genentech
Dr. Andrew J.T. George, Imperial College, United Kingdom
Dr. Stephen D. Gillies, Lexigen Pharmaceuticals Corp
Dr. Martin J. Glennie, University of Southampton, United Kingdom
Dr. David R. Glover, Cambridge Antibody Technology, United Kingdom
Dr. Lucy Holt, MRC Laboratory of Molecular Biology, United Kingdom
Dr. Annemarie Honegger, Zürich University, Switzerland
Dr. Hennie R. Hoogenboom, Dyax Corp and University of Liëge, Belgium
Dr. James S. Huston, Lexigen Pharmaceuticals Corp
Isao Ishida, Kirin Brewery Co., Ltd., Japan
Dr. Lutz Jermutus, Head of Display Technology Development, Cambridge Antibody Technology, United Kingdom
Dr. Titus Kretzschmar, Morphosys, Germany
Dr. Dasa Lipovsek, Phylos, Inc.
Dr. T. Logtenberg, Crucell N.V., The Netherlands
Dr. Nils Lonberg, Medarex
Dr. Wayne A. Marasco, Harvard Medical School
Dr. James D. Marks, University of California, San Francisco
Dr. Ole J. Marvik, Affitech AS, Norway
Dr. Serge Muyldermans, Vrije Universiteit Brussel, Belgium
Dr. Dario Neri, Swiss Federal Institute of Technology, Switzerland
Dr. Peter O. Olins, Applied Molecular Evolution, Inc.
Dr. John W. Park, University of California, San Francisco
Dr. Paul W.H.I. Parren, The Scripps Research Institute
Dr. Ira Pastan, National Cancer Institute, National Institutes of Health
Dr. R. Barbara Pedley, Royal Free and University College Medical School, United Kingdom
Dr. Alexander Pereboev, University of Alabama at Birmingham
Dr. Andreas Plückthun, Zürich University, Switzerland
Dr. Jos Raats, University of Nijmegen, The Netherlands
Dr. Mitchell Reff, IDEC Pharmaceuticals
Dr. Ralph A. Reisfeld, The Scripps Research Institute
Dr. Jamie Kathleen Scott, Simon Fraser University, Canada
Dr. Jack L. Strominger, Harvard University & Harvard Medical School
Dr. Jean-Luc Teillaud, INSERM, France
Dr. Ian M. Tomlinson, Diversys Limited, United Kingdom
Dr. Gunars Valkers, Biosite Discovery
Dr. Ellen Vitetta, The University of Texas Southwestern Medical Center at Dallas
Dr. Gerhard Wagner, Harvard Medical School
Dr. Jeffry D. Watkins, Applied Molecular Evolution, Inc.
Dr. Louis M. Weiner, Fox Chase Cancer Center
Dr. R. Anthony Williamson, The Scripps Research Institute
Dr. Jan G.J. van de Winkel, Genmab A/S, The Netherlands
Dr. K. Dane Wittrup, Massachusetts Institute of Technology
http://www.lifesciencesinfo.com/antibodyeng/?source=2680-35
Gruß Bogo!
Schaun wir mal, was die uns alles zu erzählen haben! Vielleicht gibt es ja einige Kursrelevante Meldungen. Abgenix hat ja schon mal angefangen.
Gruß Bogo!
Gruß Bogo!
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 73 | ||
| 66 | ||
| 60 | ||
| 30 | ||
| 27 | ||
| 27 | ||
| 17 | ||
| 13 | ||
| 13 | ||
| 13 |
| Wertpapier | Beiträge | |
|---|---|---|
| 13 | ||
| 12 | ||
| 12 | ||
| 11 | ||
| 10 | ||
| 9 | ||
| 9 | ||
| 9 | ||
| 8 | ||
| 8 |
